Meningitis B Vaccine UK 2026: Cost, Schedule and How Long Protection Lasts

Private MenB vaccination at a UK pharmacy in 2026 costs 100 to 195 pounds per dose. Two doses are needed for the full course.

In autumn 2025, a UK university sent notifications to households confirming an invasive meningococcal case among first-year students. The alert advised close contacts to seek prophylactic antibiotics and consider private meningitis B vaccination. Calls to pharmacies spiked. Most callers were parents of teenagers, students themselves, or adults who realised they were not eligible for the Bexsero vaccine when it was introduced on the NHS in September 2015. This article explains what meningitis B is, the difference between NHS and private vaccination, what it costs in 2026, how long protection lasts, and how to recognise the symptoms. We cover the two vaccines licensed in the UK, the practical dosing schedules, side effects, and when paying privately is a sensible choice.

What is meningitis B and why does the vaccine matter

Meningococcal group B is a strain of Neisseria meningitidis bacteria that causes invasive meningococcal disease (IMD). IMD can present as meningitis, an infection of the membranes around the brain and spinal cord, or as septicaemia, a bloodstream infection, or both. In the UK, MenB has been the most common cause of bacterial meningitis in babies and young children since the MenC vaccine was introduced in 1999. Around 1 in 10 of those who develop IMD die. Around 1 in 5 survivors live with a permanent disability such as limb amputation, hearing loss, brain damage, seizures, or chronic kidney damage. The illness can progress from first symptom to critical condition within hours.

Classic symptoms include a sudden high fever, severe headache, stiff neck, dislike of bright lights, nausea, vomiting, drowsiness, and confusion. In babies, signs include a high-pitched cry, refusing feeds, floppy or stiff posture, and mottled or blotchy skin. A non-blanching rash, where small red or purple spots do not fade when pressed with a clear glass, is a late and very serious sign. The Bexsero vaccine, introduced into the NHS routine schedule in September 2015, has cut invasive MenB disease in vaccinated UK babies by around 75 percent. This is the single biggest public health gain from any new UK vaccine in the last decade. Older teenagers and adults missed that introduction. The MenACWY vaccine given as a teenage dose in school year 9 or 10 covers meningococcal groups A, C, W and Y but not B.

NHS schedule versus private schedule in 2026

The NHS routine schedule for MenB is unchanged in 2026. Three doses of Bexsero are given at 8 weeks, 16 weeks and 1 year of age. The vaccine is free and is given alongside other routine childhood immunisations. NHS catch-up is offered if a baby missed the schedule for medical reasons, or for high-risk groups at any age. These high-risk groups include people with asplenia, a non-functioning or absent spleen, sickle cell disease, complement deficiency, and those with an occupational risk in microbiology laboratories. Beyond these groups, MenB vaccination is not currently routine for older children, teenagers or adults on the NHS. The teenage NHS dose is MenACWY, a different vaccine that does not cover group B.

For everyone else who wants MenB protection, the private route is the only option. The private MenB schedule for ages 10 and over is two doses of Bexsero given at least 1 month apart, or two doses of Trumenba given 6 months apart. An accelerated schedule is also available: two doses 1 month apart plus a booster 4 months later. Trumenba is licensed from age 10 only. Bexsero can be used at any age. Both vaccines are MHRA-licensed and available through most UK private clinics and major high-street pharmacy chains. Some clinics will offer the second dose appointment at the time of the first booking.

Bexsero versus Trumenba: what is the practical difference

Bexsero, made by GSK, is a 4CMenB vaccine. It contains four MenB antigens: factor H binding protein, NHBA, NadA, and outer membrane vesicles from a New Zealand strain. It is the UK NHS choice for the infant schedule. It has the broadest coverage of UK circulating MenB strains and has been in the NHS routine schedule since September 2015. It is licensed from 2 months of age. The schedule for adults and adolescents is two doses at least 1 month apart.

Trumenba, made by Pfizer, is a bivalent MenB-fHbp vaccine. It contains two variants of the factor H binding protein. It is licensed in the UK from age 10 only. The standard schedule is two doses 6 months apart, or three doses on an accelerated 0-1-4 month schedule. Trumenba is not used in the NHS schedule. Its coverage of UK circulating MenB strains is narrower than Bexsero. Both vaccines reduce the risk of invasive MenB disease. Bexsero has more real-world UK data because of its use in the national programme. For most UK private patients in 2026, Bexsero is the default choice. Trumenba may be offered where Bexsero is in short supply or as a clinician preference. The cost is similar for both: 100 to 195 pounds per dose. The side effect profile is also similar: injection site pain, redness, swelling, fever which is more common in infants, mild headache, and irritability. Serious adverse events are very rare with either vaccine. The choice between them is usually driven by local availability rather than clinical preference. Both protect against invasive MenB disease, but neither protects against MenACWY, which needs a separate vaccine.

What does the private meningitis B vaccine cost in the UK in 2026

The per-dose cost ranges from 100 pounds at the cheapest high-street pharmacy to 195 pounds at private travel clinics. Two doses are needed for the full course, so the total course cost ranges from 220 to 390 pounds. The cheapest UK routes in 2026 are typically Boots Pharmacy, around 110 to 130 pounds per dose, Superdrug Health Clinic, around 110 to 140 pounds per dose, LloydsPharmacy, around 120 to 140 pounds per dose, and Will Chemists, around 100 to 120 pounds per dose. Mid-range options include City Doc and online doctor services at 140 to 160 pounds per dose. Higher-end travel clinics like MASTA and the Fleet Street Clinic charge 160 to 195 pounds per dose.

The total course cost is what you need to budget for: 220 to 390 pounds depending on the provider. Some clinics offer a package price for both doses booked together at a small discount. Consultation fees are usually included in the vaccine fee at high-street pharmacy chains. Travel clinics may charge a separate consultation fee. Booking the second dose at the time of the first is the most reliable way to keep the schedule on track. Online doctor services from Boots, Superdrug, and Lloyds Online Doctor offer a video consultation with a UK GP and a voucher to redeem at a local branch. Most UK private medical insurance policies do not cover routine vaccination; MenB is rarely covered unless tied to an outbreak contact or a specific occupational pathway.

How long does the meningitis B vaccine last

The exact duration of protection from the MenB vaccine is not fully established. Real-world UK data from the NHS Bexsero programme since September 2015 has shown a sustained reduction in invasive MenB disease in the cohort of vaccinated children for at least the first 5 years of life. Antibody studies after a primary course in adolescents and adults suggest protective antibody levels last for at least 2 to 4 years. Beyond 4 years the antibody data is less complete. Whether a booster dose is needed is not currently routine policy in the UK. The Joint Committee on Vaccination and Immunisation (JCVI) reviews this regularly. Specific groups already get boosters: people with asplenia, complement deficiency, and microbiology laboratory staff. Boosters may be considered case by case for travellers to outbreak regions or close contacts of confirmed cases.

For most private patients, the two-dose course gives a measurable boost in MenB-specific antibody and a reduction in disease risk for at least several years. The protection is not lifelong on current evidence. There is no UK national booster programme for MenB in 2026 outside high-risk groups. If you had your private course 5 or more years ago and you remain in a higher-risk environment, such as close-contact university accommodation, occupational microbiology, or travel to an outbreak region, discuss a booster with your GP or private clinic. Antibody testing before a booster is rarely needed; the vaccine is well tolerated and safer to give than to test for need.

Who should consider the private MenB vaccine in 2026

Group 1: university freshers moving into shared first-year accommodation. Halls of residence, shared kitchens and bathrooms, and close social mixing in the first weeks of term are the highest-risk period in UK adult life for invasive MenB. Consider booking both doses before the start of term: first dose 4 to 8 weeks before move-in, second dose at least 4 weeks later.

Group 2: household contacts or close school contacts of a recent confirmed invasive meningococcal case. The NHS will offer prophylactic antibiotics like ciprofloxacin or rifampicin to close contacts but does not routinely offer free MenB vaccination outside high-risk groups. Private MenB is a sensible add-on.

Group 3: travellers to outbreak regions, particularly the sub-Saharan African meningitis belt from Senegal to Ethiopia. MenACWY is the priority for that travel but MenB protection is a reasonable addition.

Group 4: occupational exposure. Microbiology laboratory staff handling Neisseria meningitidis already get this free on the NHS schedule.

Group 5: parents who want their teenager protected before sixth form or college boarding.

Group 6: anyone who missed the NHS Bexsero schedule as a baby and remains in a higher-risk environment. The vaccine is not currently routine for people in their 30s, 40s or older in average-risk environments. Risk falls steeply after age 25. The conversation with your GP or private clinician should focus on your specific exposure rather than a blanket age cutoff. Cost is the main barrier for most. Two doses at 100 to 195 pounds per dose remains the typical UK private spend in 2026.

How to spot meningitis and what to do

The classic symptoms of bacterial meningitis are a sudden high fever, a severe headache that is worse than a normal headache, a stiff neck where you cannot bring your chin to your chest comfortably, photophobia where light hurts your eyes, nausea or vomiting, and drowsiness or confusion. In babies and toddlers, signs include a high-pitched cry, refusing feeds, floppy or stiff posture, pale or mottled skin, and a bulging fontanelle. Septicaemia, or meningococcal sepsis, warning signs include cold hands and feet despite a high temperature, fast breathing, severe muscle pain especially in the legs, mottled or blotchy skin, and drowsiness.

The non-blanching rash, small red, brown or purple spots that do not fade under pressure, is a late and very serious sign. The Glass Test involves pressing the side of a clear drinking glass firmly against the rash. If the spots do not fade or disappear under the pressure, this is a red flag for meningococcal septicaemia. The action plan is clear: do not wait for the rash. If meningitis or septicaemia is suspected based on fever, severe headache, stiff neck, drowsiness or any septicaemia warning sign, call 999 or go to A and E immediately. NHS 111 is appropriate only if symptoms are mild and uncertain. Hospital treatment with intravenous antibiotics such as ceftriaxone or benzylpenicillin within 1 hour of arrival saves lives. Steroids may be added in adults. The outcome correlates closely with the time from first symptom to first antibiotic dose.

Frequently Asked Questions

Is the meningitis B vaccine free on the NHS for teenagers?

No. The NHS routine MenB vaccine, Bexsero, is given to babies at 8 weeks, 16 weeks and 1 year. Teenagers and adults are not routinely vaccinated against MenB on the NHS. The teenage NHS vaccine given in school year 9 or 10 is MenACWY, which covers meningococcal groups A, C, W and Y but not B. Free NHS MenB for teenagers and adults is reserved for specific high-risk groups only. These include people with asplenia, complement deficiency, sickle cell disease, and microbiology laboratory staff.

How much does the private meningitis B vaccine cost in the UK in 2026?

The per-dose cost ranges from 100 pounds at the cheapest high-street pharmacy to 195 pounds at travel clinics. Two doses are needed for a full course, so the total course cost ranges from 220 to 390 pounds. Major UK providers include Boots, Superdrug, LloydsPharmacy, Will Chemists, City Doc, MASTA, and the Fleet Street Clinic. Booking both doses together at the same provider is the most reliable way to stay on schedule. Most UK private medical insurance does not cover routine MenB vaccination.

How many doses do I need and how far apart?

You need two doses given at least 1 month apart with Bexsero, or two doses 6 months apart with Trumenba. An accelerated three-dose schedule for faster protection is available: two doses 1 month apart plus a booster 4 months later. The full course gives a measurable boost in MenB-specific antibody. Booking both doses at the time of the first booking is the most reliable way to keep the schedule on track. NHS babies get three doses at 8 weeks, 16 weeks and 1 year.

How long does the meningitis B vaccine last?

The duration of protection is not fully established. Real-world UK data from the NHS Bexsero programme since 2015 shows a sustained reduction in invasive MenB disease in vaccinated children for at least 5 years. Antibody data in adolescents and adults suggests protection lasts at least 2 to 4 years. Routine boosters are not currently recommended outside high-risk groups like asplenia, complement deficiency, and microbiology lab staff. Discuss a booster with your GP or private clinic if you remain in a higher-risk environment 5 or more years after your primary course.

Should my child have MenB before starting university?

Yes, if you can. Halls of residence in the first weeks of term are the highest-risk UK environment for invasive MenB in adult life. Book both doses before move-in: first dose 4 to 8 weeks before term starts, second dose at least 4 weeks later. The accelerated schedule, two doses 1 month apart plus a 4-month booster, is an option if you book later. The cost is typically 220 to 390 pounds for the course at a UK high-street pharmacy or private clinic.

What are the side effects of the MenB vaccine?

Common side effects include injection-site pain, redness and swelling for 1 to 3 days, mild fever which is more common in infants on the NHS schedule where prophylactic paracetamol is given, mild headache and irritability. Serious adverse events are very rare. Anaphylaxis is extremely rare and clinics carry adrenaline. Mild illness is not a contraindication. Severe allergy to a previous dose or a vaccine component is a contraindication. Pregnancy is a precaution; discuss with a specialist if you are pregnant and at high risk.

How do I recognise meningitis and what should I do?

Classic symptoms include a sudden high fever, severe headache, stiff neck, photophobia, nausea or vomiting, and drowsiness or confusion. Septicaemia signs include cold hands and feet despite fever, fast breathing, severe muscle pain, and mottled skin. The non-blanching rash is a late sign. Do not wait for the rash. Call 999 or go to A and E immediately. Hospital intravenous antibiotics with ceftriaxone or benzylpenicillin within 1 hour of arrival save lives. Outcome depends on the speed of treatment.

This article is informational only and does not replace personalised advice from your GP, pharmacist, or another qualified healthcare professional.